Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Read at CNBC(opens in a new tab)
Full coverage
Novo says Wegovy injection lowers BMI and obesity rates in children in trial (opens CNBC in a new tab)
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

